ID
15654
Description
Alemtuzumab in Autoimmune Inflammatory Neurodegeneration: Mechanisms of Action and Neuroprotective Potential (ALAIN01) https://clinicaltrials.gov/ct2/show/NCT02419378 Principal Investigator Prof. Dr. Dr. Sven Meuth, University Hospital Muenster, Germany Part: Relapse Evaluation Visit No. X
Link
https://clinicaltrials.gov/ct2/show/NCT02419378
Keywords
Versions (2)
- 6/6/16 6/6/16 -
- 6/6/16 6/6/16 -
Uploaded on
June 6, 2016
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Relapse Evaluation Visit No. X: Recent Symptoms Multiple Sclerosis ALAIN01 NCT02419378
Relapse Evaluation Visit No. X: Recent Symptoms Multiple Sclerosis ALAIN01 NCT02419378
Description
Relapse: Recent symptoms RQG
Description
Relapse: Recent symptoms description
Data type
text
Alias
- UMLS CUI [1]
- C1457887
Description
Relapse: Recent symptoms Start Date
Data type
date
Alias
- UMLS CUI [1,1]
- C1457887
- UMLS CUI [1,2]
- C2826738
Description
Relapse: Recent symptoms End Date
Data type
date
Alias
- UMLS CUI [1,1]
- C1457887
- UMLS CUI [1,2]
- C2826747
Description
Relapse Visit Number
Data type
integer
Alias
- UMLS CUI [1,1]
- C1549755
- UMLS CUI [1,2]
- C0277556
Description
Relapse: Recent symptoms ongoing
Data type
text
Alias
- UMLS CUI [1,1]
- C1457887
- UMLS CUI [1,2]
- C0150312
Similar models
Relapse Evaluation Visit No. X: Recent Symptoms Multiple Sclerosis ALAIN01 NCT02419378
C2826738 (UMLS CUI [1,2])
C2826747 (UMLS CUI [1,2])
C0277556 (UMLS CUI [1,2])
C0150312 (UMLS CUI [1,2])